Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Clinical trial NCT06415773 · COMPLETED

Trial details

NCT number: NCT06415773
Sponsor: Shenzhen HighTide Biopharmaceutical Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2024-06-04
Primary completion: 2025-06-13
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.